NCT00148863View on ClinicalTrials.gov

Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

August 31, 2007

Conditions
Hepatitis C, Chronic
Interventions
DRUG

Peg-interferon alpha 2a (drug)

DRUG

Ribavirin (drug)

DRUG

Interferon gamma (drug)

Trial Locations (2)

33604

Hopital Haut Leveque Service d'Hepato-Gastro-Enterologie, Pessac

Hôpital du Haut-Levêque, Pessac

Sponsors

Collaborators (1)

InterMune
All Listed Sponsors
collaborator

InterMune

INDUSTRY

collaborator

Hoffmann-La Roche

INDUSTRY

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV

NCT00148863 - Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C | Biotech Hunter | Biotech Hunter